By Denny Jacob

Chemours forecasts second-quarter sales to be high end of its prior range, helped by increased sequential growth in a key segment.

The chemicals company previously forecast overall sales to increase in the low to mid-teens sequentially from first-quarter revenue of $1.37 billion and consolidated adjusted earnings before interest, taxes, depreciation and amortization to be up between 40% and 45%.

Chemours on Wednesday also disclosed second-quarter adjusted Ebitda is now projected to range between $215 million and $225 million. Analysts polled by FactSet expected $236 million.

By segment, thermal & specialized solutions is expected to see a sequential increase in sales of about 25% on demand for Opteon refrigerants. Adjusted Ebitda is expected to be up sequentially by nearly 40%.

Advanced performance materials, meanwhile, is anticipated to be within original expectations of low teens sequential growth but adjusted Ebitda is expected to rise 25% sequentially.

Titanium technologies is expected to report sales in line with the segment's high single-digit growth expectations. Adjusted Ebitda, however, is seen down 15% sequentially because of operational disruptions, mainly caused from a rail line service interruption that affected feedstock mix. The issue led to higher costs totaling $15 million while costs from other disruptions is expected at about $10 million, the company said.

Chemours also expects overall corporate costs to be slightly higher in the second quarter due to a continuing pollution trial in New Jersey.

The company is accused of violating environmental laws linked to manufacturing operations at a southern New Jersey site.

Write to Denny Jacob at denny.jacob@wsj.com

(END) Dow Jones Newswires

June 18, 2025 09:03 ET (13:03 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.